205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
8.08%
Similar revenue growth to MCHP's 9.04%. Walter Schloss would investigate if similar growth reflects similar quality.
9.61%
Cost increase while MCHP reduces costs. John Neff would investigate competitive disadvantage.
4.16%
Gross profit growth below 50% of MCHP's 17.50%. Michael Burry would check for structural issues.
-3.63%
Margin decline while MCHP shows 7.76% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1883.76%
Operating expenses reduction while MCHP shows 17.19% growth. Joel Greenblatt would examine advantage.
-347.83%
Total costs reduction while MCHP shows 6.91% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-418.18%
D&A reduction while MCHP shows 45.00% growth. Joel Greenblatt would examine efficiency.
2788.32%
EBITDA growth exceeding 1.5x MCHP's 23.91%. David Dodd would verify competitive advantages.
2572.37%
EBITDA margin growth exceeding 1.5x MCHP's 13.64%. David Dodd would verify competitive advantages.
2800.34%
Operating income growth exceeding 1.5x MCHP's 18.06%. David Dodd would verify competitive advantages.
2583.50%
Operating margin growth exceeding 1.5x MCHP's 8.27%. David Dodd would verify competitive advantages.
-81510.00%
Other expenses reduction while MCHP shows 200.00% growth. Joel Greenblatt would examine advantage.
-0.71%
Pre-tax income decline while MCHP shows 20.55% growth. Joel Greenblatt would examine position.
-8.14%
Pre-tax margin decline while MCHP shows 10.55% growth. Joel Greenblatt would examine position.
-4.21%
Tax expense reduction while MCHP shows 20.00% growth. Joel Greenblatt would examine advantage.
1.08%
Net income growth below 50% of MCHP's 20.69%. Michael Burry would check for structural issues.
-6.48%
Net margin decline while MCHP shows 10.68% growth. Joel Greenblatt would examine position.
-15.38%
EPS decline while MCHP shows 20.36% growth. Joel Greenblatt would examine position.
-15.38%
Diluted EPS decline while MCHP shows 20.36% growth. Joel Greenblatt would examine position.
0.25%
Share count increase while MCHP reduces shares. John Neff would investigate differences.
-0.83%
Both companies reducing diluted shares. Martin Whitman would check patterns.